Company Filing History:
Years Active: 2013-2017
Title: Hidemasa Jinguji: Innovator in Cell Culture Technology
Introduction
Hidemasa Jinguji is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of cell culture technology, holding a total of 3 patents. His work focuses on improving the efficiency and effectiveness of cell culture methods, which are crucial for various biological and medical applications.
Latest Patents
Jinguji's latest patents include a cell culture evaluation system, a cell culture evaluation method, and a cell culture evaluation program specifically designed for measuring suspension cells. These innovations provide a comprehensive approach to estimating and evaluating the lag time or minimum doubling time of cell populations. By utilizing the average projected area of cultured cells and the rate of increasing non-single-cells, his inventions enable researchers to objectively determine whether a cell population is stimulated for proliferation. The system captures images of the cultured cell population, calculates average projected areas, and discriminates between single-cells and non-single-cells to assess growth dynamics effectively.
Career Highlights
Hidemasa Jinguji is currently employed at Medinet Co., Ltd., where he continues to develop innovative solutions in cell culture technology. His work has been instrumental in advancing methodologies that enhance cell culture efficiency while minimizing cell damage.
Collaborations
Jinguji collaborates with esteemed colleagues such as Norihiko Hata and Naoko Ariyoshi, contributing to a dynamic research environment that fosters innovation and development in cell culture practices.
Conclusion
Hidemasa Jinguji's contributions to cell culture technology exemplify the impact of innovative thinking in scientific research. His patents not only advance the field but also provide valuable tools for researchers working with cell cultures.